Latest / CLEs You Actually Want to Hear / Cannabis After Schedule III: What Reclassification Means for California Practice
Transcript
- 0:03Hello, everyone. Welcome to today's program,
- 0:07Cannabis After Schedule 3, What Reclassification
- 0:11Means for California Practice. I'm Alla Policastro,
- 0:14Director of Education and Professional Development,
- 0:17and I am delighted to introduce our speakers
- 0:19today, Erin Lachant, Shay Gilmore, and Lavonne
- 0:22Lawson. Shay is the founder of the law offices
- 0:26of Shay Aaron Gilmore. He's a leading cannabis
- 0:28business attorney in California and a recognized
- 0:31expert in corporate and commercial transactions
- 0:33throughout the cannabis supply chain. Shay works
- 0:36exclusively with cannabis operators and investors
- 0:39on regulatory, administrative law, real estate,
- 0:42land use, corporate, labor and employment, and
- 0:45intellectual property matters. Shay has been
- 0:47recognized by the Los Angeles and San Francisco
- 0:50Daily Journal as one of the top 20 cannabis lawyers
- 0:54in California and Super Lawyers Magazine has
- 0:57named Shay in Northern California Super Lawyer
- 0:59in Cannabis Law and in Business and Corporate
- 1:01Law. Aaron is a partner at Leach Tishman in Los
- 1:05Angeles where he focuses on cannabis regulatory
- 1:08compliance and licensing matters, as well as
- 1:11healthcare corporate transactions and government
- 1:13investigations. He co -authored Proposition D,
- 1:16the landmark Los Angeles legislation that provided
- 1:19legal protections to approximately 135 medical
- 1:22marijuana dispensaries. He has since helped roughly
- 1:2545 of those businesses remain open and operational.
- 1:28Recognized by best lawyers, Erin regularly serves
- 1:32as outside general counsel to cannabis businesses
- 1:34and has advised clients on M &A transactions,
- 1:39partnership disputes, and licensing applications
- 1:41and enforcement defense across California. And
- 1:44moderating today's program is Lavonne. Lavonne
- 1:47is counsel at Leach -Tishman, where she specializes
- 1:50in tax reporting, compliance, controversy, litigation,
- 1:53and estate planning for a broad range of clients
- 1:55from startups to large corporations. Before joining
- 1:58the firm, she served as senior attorney with
- 2:00the IRS Office of Chief Counsel, where she represented
- 2:04the IRS and U .S. Tax Court and advised Department
- 2:07of Justice attorneys on tax matters. She also
- 2:10brings experience in international tax compliance,
- 2:13shore asset reporting, and previously ran her
- 2:16own law practice handling federal and California
- 2:18state tax matters. We're so excited to hear what
- 2:21they have to share with us today. So I'm now
- 2:23going to turn it over to them. Thank you. And
- 2:26hi, everyone. It is my pleasure to moderate this
- 2:28program on cannabis and reclassification. For
- 2:32decades, marijuana has been treated as what we
- 2:34call a schedule one substance, the most restrictive
- 2:36federal category. As will be discussed, qualifying
- 2:40marijuana has been reclassified as Schedule 3.
- 2:44Reclassification can, for many, affect tax treatment,
- 2:47research, regulatory compliance, health care
- 2:49issues, employment policies, transactions, banking,
- 2:52and more. It may also change how clients evaluate
- 2:55opportunities and obligations in an industry
- 2:57that remains highly regulated and legally uncertain.
- 3:01Today, our speakers will focus on how reclassification
- 3:04happened, what reclassification would and would
- 3:07not do, what is happening in the marketplace
- 3:09already, and what practical issues practitioners
- 3:12should be considering as the process moves forward.
- 3:16Questions can be taken during the discussion
- 3:18where applicable or at the end. We will endeavor
- 3:21to find time for questions accordingly. And so
- 3:25I'm going to start with Shay. Shay, how did reclassification
- 3:28finally happen? Thank you, Levon, and thank you
- 3:34to the Beverly Hills Bar Association for putting
- 3:38together this program. So, I mean, most people,
- 3:45to answer your question, Levon, people picture
- 3:50a switch getting flipped, but really, it's the
- 3:55opposite. And when you talk about how rescheduling
- 3:58actually happened, You really are talking about
- 4:04a formal and really the most formal kind of federal
- 4:09rulemaking there is. As I'll talk about in my
- 4:14slides here, the attorney general has the authority
- 4:19delegated to the DEA administrator, and Health
- 4:25and Human Services does the scientific and medical
- 4:28analysis. that science binds the DEA. They can't
- 4:37substitute their own view. And we'll talk a little
- 4:40bit about the eight -factor test that you've
- 4:43heard about, I'm sure, in some of the news coverage.
- 4:47That's what the DEA applies. But I guess to start
- 4:53us off, in a nutshell, what we're talking about
- 4:59here at the beginning is process. And Aaron's
- 5:03going to pick up at the other side of this to
- 5:07talk about what's already happened. But I'm going
- 5:11to talk about what just finished only a couple
- 5:14of days ago. but could lead to an expansion of
- 5:18what has already happened. So it's not really
- 5:22the most glamorous part of this program, but
- 5:27it might be the most important if it goes the
- 5:31way that I think the movement would like. You
- 5:35know, the whole industry has spent two years
- 5:37asking when does cannabis get rescheduled? And
- 5:42the honest answer to the, you know, question
- 5:46answered in whole of that is really how it lives
- 5:52and how this machinery works. So, right. In the
- 5:56next slide, what do California operators get
- 6:00out of this part one that I'm going to talk about
- 6:02here? And I'll pick up the pace because I know
- 6:07there's lots of information to get out there.
- 6:10But three things. One, A, how the process works
- 6:14and why the history should make you skeptical
- 6:17of anyone promising that Schedule 3 expansion
- 6:21is a done deal. We just don't know until it's
- 6:25over. And even though the hearing is concluded,
- 6:27as you'll see later, it isn't over even after
- 6:33that. Second, the 2024 hearing for context shows
- 6:40how these things can just stall. And I'll go
- 6:43through just because I think any lawyer that's
- 6:46going to advise their client in this space needs
- 6:49to be aware of the history, the very on point
- 6:53history that came just within the last not even
- 6:57three years. and I think that history informs
- 7:01this process. And then third, the hearing that
- 7:05just are wrapped and what it signals for operators
- 7:09in California. I mean, the process really is
- 7:13the risk, as we'll see unfold through these slides.
- 7:22Next slide. Rescheduling is a formal, on -the
- 7:32-record rulemaking. And here are the mechanics.
- 7:37So this isn't a memo that someone signs. It's
- 7:41a formal rulemaking. The attorney general can
- 7:44start it, and his or her authority runs down
- 7:49to the DEA administrator. So what's... The key
- 7:54in this process is that Health and Human Services
- 7:58Science binds the DEA. So the DEA doesn't substitute
- 8:02its own scientific judgment. The DEA instead
- 8:08applies an eight -factor test and the schedule
- 8:13criteria. probably heard about, in fact, you
- 8:17probably, or you did hear in the introduction
- 8:20to this program, the word schedule one. Well,
- 8:25that refers to the schedules that live on the
- 8:29Controlled Substances Act of 1970. And just like
- 8:35you heard, just like you heard in the beginning
- 8:42of this program, Canvas has been schedule one
- 8:46marijuana rather has been schedule one all this
- 8:48time up until April twenty twenty six and when
- 8:54medical and FDA approved products were rescheduled
- 8:58to schedule three. So because the statute says
- 9:01on the record after a hearing it triggers full
- 9:06formal. rulemaking before an administrative law
- 9:11judge and final orders go to the DC Circuit.
- 9:15Remember that court. Next slide. So the administrative
- 9:24law judge recommends and the DEA decides. That's
- 9:30the structure of this. And it's really kind of
- 9:36important to manage your client's expectations
- 9:38here because the ALJ runs the hearing, but doesn't
- 9:45actually decide the case. The judge issues a
- 9:49recommendation at the end. and the DEA administrator
- 9:54then reviews de novo and makes the call. So think
- 9:59about that for a second, right? The DEA is both
- 10:02the party proposing the rule and the judge of
- 10:06it at the same time. So you really have to kind
- 10:10of like... look at this process with a lot of
- 10:15skepticism about really the, I guess, kind of
- 10:21like legitimacy of it from what we would consider
- 10:25as lawyers to be a fair process for determining
- 10:32issues. When a client says the hearing went well
- 10:36or they're hearing stuff in the news, And so
- 10:41we must be good. I think the good advice to hand
- 10:46them is to keep this all in context of the process
- 10:53and what each role player has the authority to
- 10:57do. Next slide. So I'm going to go through the
- 11:04chronology really quickly here just so that you
- 11:06understand this did not just happened in April
- 11:11of this year. This actually got kicked off in
- 11:15October of 2022. So almost four years ago, under
- 11:21the Biden administration, the Biden Health and
- 11:25Human Services Department recommended schedule
- 11:28three, not for medicinal and FDA approved products
- 11:35like we eventually got. They just fully represented,
- 11:39recommended, schedule three. And in 2023, this
- 11:47or that recommendation came out in 2023. DOG
- 11:52published the rule in May 2024. They took public
- 11:56comment. There were 43 ,000 comments that came
- 11:59in. A large majority of them were in favor. And
- 12:04this resulted in a hearing. There were 163 applicants
- 12:09to participate in that hearing. 25 designated
- 12:14participants. I think there was some griping
- 12:18about who got to get in and who didn't. All that
- 12:22griping seems kind of quaint now, given what
- 12:26happened in the second round, as you'll see.
- 12:29You know, there was a good mix at that time in
- 12:33that hearing of pro and anti -rescheduling voices.
- 12:37The preliminary hearing got kicked off in 2024
- 12:45in December and went off the rails from there.
- 12:52Next slide. What do you mean by off the rails?
- 12:59You bet. So I'm so glad you asked because now
- 13:02I get to introduce you to my good friend Shane
- 13:06Pennington. He's a colleague of mine, a brilliant
- 13:12lawyer, writes prolifically in this space. And
- 13:18when this first round of the DEA hearing had
- 13:26gotten underway, Shane Paynton came along to
- 13:30take it right off the rails. And he challenged
- 13:34the hearing and how the hearing had come together.
- 13:43He filed a 57 -page motion. uh, to disqualify
- 13:48the DEA as the proponent, arguing that the DEA
- 13:53had signaled it opposed its own rule and couldn't
- 13:57carry the burden, alleging improper contacts
- 14:00with opponents. Um, I can tell you, like, watching
- 14:05from the sidelines at the time this was going
- 14:07on, uh, I really kind of, you know, was just
- 14:12picking things up from the news as they were
- 14:14happening, but it was high drama and kept me
- 14:18on the edge of my seat, for sure. The judge ended
- 14:24up denying the motion, but granted an interlocutory
- 14:29appeal, canceled the merits hearing. That's the
- 14:33important piece here and warning of irrevocable
- 14:37taint. Um, I mean, basically you, you had, uh,
- 14:44you know, I don't think you can argue with a
- 14:47lot of the points that Shane made because they
- 14:49were very well constructed and he had really
- 14:54solid legal arguments. The problem was that there
- 14:58was about to be a political change in the administration,
- 15:01right? And this was kind of like, the last window
- 15:06to get something through. And of course, that's
- 15:10what happened, right? Biden lost the election.
- 15:13The process then died because the administration
- 15:18changed over. Just like we'll change over to
- 15:22the next slide. So in cannabis, you can really
- 15:29think of falling into two buckets. schedule three
- 15:36and schedule one. The piece that confuses everyone,
- 15:43people are saying cannabis got rescheduled in
- 15:46April. Well, it's really only half true because
- 15:51the only pieces of the larger marijuana bucket
- 15:58that were taken out of schedule one into schedule
- 16:01three in April are FDA approved products, and
- 16:06state licensed medical cannabis. And this was
- 16:13done through the treaty process. There's a very
- 16:18intricate background that probably is outside
- 16:22the scope of this presentation, but it is already
- 16:28subject to a legal challenge. And so, you know,
- 16:32even the stuff that Aaron's going to talk about
- 16:35in his part. could all go away because the legal
- 16:41challenge succeeds, right? And that DC Circuit
- 16:43case just decides to take everything back to
- 16:47where it was before. California's market, core
- 16:54commercial market is vastly adult use. And so
- 17:00like Aaron's gonna talk to you about in his part,
- 17:03It's a really different situation here in California
- 17:07than it is in a place like Florida or Oklahoma,
- 17:12where, you know, it's a red state, I'll point
- 17:14out, and all they have is medical. So this is
- 17:19a policy giveaway to them where for states like
- 17:25California, who are vastly adult use. Illinois,
- 17:31other large states that have large markets with
- 17:36both adult use and medical, this is a policy
- 17:39nightmare relatively. Next slide. hearing that
- 17:52just concluded actually is, you know, the medical
- 17:56has already moved to schedule three and this
- 18:00hearing that just concluded is only about adult
- 18:04use expansion into the schedule three bucket.
- 18:08So there's a new judge, Chief Administrative
- 18:13Law Judge, Derek Julius, and you know, there's
- 18:19Only seven participants this time around and
- 18:23every one of them as opposed to rescheduling
- 18:25You know, I Think there are a lot of people reading
- 18:30from that Oh doom and gloom. I you know, I don't
- 18:34know is the answer But I think just like we saw
- 18:38with the process that came before, nobody saw
- 18:41Shane Pennington coming around and taking it
- 18:44all off the rails, right? You know, things can
- 18:46happen. And the administrative law just judge
- 18:50Julius has now set an August 17th deadline for
- 18:54post hearing briefs and gave no timeline for
- 18:57his recommendation. And remember, it's just a
- 18:59recommendation that the DEA gets to adopt or
- 19:03not. Next slide. So how does this hearing that
- 19:10just concluded differ from the one in 2024? Well,
- 19:16New Judge, for one. Another difference is there
- 19:21were 25 participants representing both sides
- 19:24in 2024. Here, there were seven and only the
- 19:28opponents. scope here is narrowed to only adult
- 19:33use. In 2024, you didn't have any rescheduling
- 19:37already, so now you do as this hearing is going
- 19:41on. The DEA, as the proponent problem that Pennington
- 19:48litigated, that was mooted by terminating the
- 19:53old docket And this week in some of the news
- 19:58reports, there's been a lot of people calling
- 20:02it like a one -sided record. I think that we
- 20:08just have to wait and see. I think looking at
- 20:11the briefs in August is going to be helpful to
- 20:14kind of crystallize what it is that the judge
- 20:17will be grappling with at the end. Next slide.
- 20:24Alright, so the open questions that we've got
- 20:27as this hearing finished a couple of days ago.
- 20:33Four things. One, you know, one side was excluded.
- 20:38DEA said reform supporters weren't aggrieved.
- 20:43So, okay. So California's license industry had
- 20:46no seat at this. Normal, file the challenge.
- 20:51uh and it didn't it didn't work out um the record
- 20:55too the record was built for a different question
- 20:57medical use evidence uh it supports the bucket
- 21:03that already moved yet the hearing asks about
- 21:06adult use uh so You know, the situation that
- 21:11we're in right now is a hybrid system, and this
- 21:15was about unifying it all under Schedule 3 or
- 21:19leaving it in this now status quo of a two -part
- 21:23system. Um, three, that DC circuit challenge
- 21:26that I mentioned, it's still pending and, uh,
- 21:30the DOJ conceded, uh, that there's ALG removal
- 21:34problem, ALJ removal problems, uh, in related
- 21:37litigation. And then, uh, four, there is no deadline
- 21:41on the decision maker. So I don't think you can,
- 21:45you know, build any firm dates off of what you've
- 21:48seen so far. Uh, and then, uh, last slide I have
- 21:51before I hand it over, uh, to my colleagues,
- 21:54you know, what this means for California practice,
- 21:59you know, one rescheduling is not legalization.
- 22:04Even what has already happened, um, in April
- 22:09and even this expansion, uh, that is getting,
- 22:13that just got finished getting considered. does
- 22:17not mean cannabis has been legalized. It's just
- 22:19been moved on a schedule of controlled substances
- 22:25that remain federally illegal. I think another
- 22:33thing to keep in mind is that federal relief
- 22:37is not state relief and it doesn't flow down
- 22:42automatically. Take a look at Wyoming's attorney
- 22:46general and what he did this month relating to
- 22:51marijuana. And then finally, look... at the fact
- 22:55that a final rule here is not imminent, even
- 22:58though this is just concluded. As I just mentioned,
- 23:01the ALJ has set an August date for a post -hering
- 23:05briefing, and then there's a recommendation,
- 23:07and then there's a final call from the administrator
- 23:12on that recommendation. So we're looking out,
- 23:16you know, months, not weeks, for a result on
- 23:22the expansion of the scheduling that's already
- 23:25taken place. And for that, I will hand it over
- 23:28to my colleague to talk about what this means
- 23:32for California operators. Certainly. And thank
- 23:37you, Shay. And does this mean then that we don't
- 23:41have an effective date, even though we have this
- 23:44final order that's come out and so forth from
- 23:47DOJ order? Well, we do not have a date for the
- 23:59decision. And it's even more precise to say that
- 24:03we don't have a date for the recommendation that
- 24:06precedes the decision, right? So we not only
- 24:10don't have a date for the decision, we don't
- 24:12even have a date for the thing that comes before
- 24:15the decision. But importantly, the rescheduling
- 24:21that Erin is going to talk about has already
- 24:24been decided. It was decided in April, and it
- 24:28was published in the Federal Register on April
- 24:3028th. And so that has happened. It is a reality
- 24:34right now. Well, thank you for taking us through
- 24:38that, because it is incredibly complicated, apparently,
- 24:41this process. So thank you very much. Before
- 24:44we go to Aaron, who is going to really get into
- 24:47the meat and potatoes of the impact of all of
- 24:50this is just a few quick questions about some
- 24:53of the tax implications. Suzanne, could we put
- 24:55up part two handout? And while that's happening,
- 25:01if we could go to page six, start there. But
- 25:05one of the most significant practical effects
- 25:08of moving qualifying cannabis activity from schedule
- 25:11one to schedule three is the potential for removing
- 25:14the impact on that activity of Internal Revenue
- 25:17Code Section 280E. So Section 280E disallows
- 25:22deductions and credits for businesses that are
- 25:25trafficking in schedule one or two substances.
- 25:30So for those businesses, they're not allowed
- 25:33to take ordinary and necessary deductions, which
- 25:37incredibly distorts the activity. Being at schedule
- 25:42one or two really left businesses only able to
- 25:44recover their cost of good soul. It distorts
- 25:47the business operations. People are trying to
- 25:49put as much into cost of good soul as they can.
- 25:51And it leaves up businesses with very high effective
- 25:53tax rate and significant cash flow problems.
- 25:57to the extent that qualifying cannabis activity
- 26:00that medical marijuana and or marijuana use in
- 26:06FDA approved products to the extent that those
- 26:09can be considered as are considered schedule
- 26:11three or certainly are no longer treated schedule
- 26:13one or two. operators will be able to deduct
- 26:16ordinary and necessary business expenses, such
- 26:19as payroll, rent, professional fees, marketing,
- 26:22administrative costs subject, of course, to final
- 26:26federal rules and guidance. So this is all speculative.
- 26:28But that would be the impact, which significantly
- 26:34changes the situation for those dealing with
- 26:36that activity. So if we could go to the next
- 26:42page. Thank you. So again, this is kind of more
- 26:47of the same, but just notes, as Shay had pointed
- 26:50out, the distinction that Schedules 3 really
- 26:52only regards certain activity, marijuana activity,
- 26:56and FDA -approved marijuana drug products, versus
- 26:59adult use and recreational, non -covered marijuana,
- 27:04bulk marijuana. That would still be under Schedule
- 27:071. So for these purposes, Schedule 3 treatment
- 27:10is important for tax purposes. But as she noted,
- 27:15even nonetheless, federal controlled substance
- 27:18regulation continues. Meanwhile, so there's going
- 27:22to be a number of issues as people. a way to
- 27:25figure out when this becomes effective. But they're
- 27:29going to be tax positions. We're going to be
- 27:31worried about effective dates. They're going
- 27:33to be worried about, even for tax purposes, federal
- 27:36registration, state licensing, and definitely
- 27:39forthcoming guidance. Next page, please. All
- 27:45right. So here, again, we're comparing the items.
- 27:51This is schedule three. Next page. And the next
- 27:56page really is schedule one. All right, so then
- 27:59if we could go to page 10, and that's really
- 28:02just setting forth a comparison chart regarding
- 28:06the treatment for schedule three versus schedule
- 28:10one activity. Again, you get your expenses on
- 28:12schedule three. Schedule one, you are really
- 28:15not getting your expenses. You're just left being
- 28:17able to take your cost of goods sold. If there's
- 28:20an audit focus, we would think that schedule
- 28:22three, one is, one would be determining whether
- 28:25this product really qualifies for qualification,
- 28:28so they can get the benefits that any other business
- 28:31would get. I wouldn't say regular, but most businesses
- 28:34would get, with respect to ordinary necessary
- 28:37expenses, what's the effective date, and allocation,
- 28:40which will be discussed shortly. An audit with
- 28:42respect to Schedule 1 activity would be focusing,
- 28:45presumably, on cost of goods sold and Section
- 28:48280E compliance. Next page, please. So there's
- 28:55going to be timing and transition rules. So,
- 29:00you know, what I would say, there are questions
- 29:03that are out there. The Treasury and the IRS
- 29:06issued an announcement. dated April 23rd, 2026,
- 29:11indicating a process for tax guidance following
- 29:14the DOJ final order on medical marijuana rescheduling.
- 29:17The announcement indicated a plan to issue guidance
- 29:19to address a couple of tax issues. Well, principal
- 29:23tax issues. There's gonna be more than a couple,
- 29:26but also what was also articulated was, excuse
- 29:31me, I have some sort of document which is opened
- 29:33up. guidance with respect to bifurcation, where
- 29:38you have an enterprise that has more than one
- 29:42activity. Say they have a medical marijuana activity
- 29:46under schedule that is now classified under schedule
- 29:48three, or presumably would be classified under
- 29:53schedule three. And where they also have operations
- 29:56in product that would be classified under schedules
- 30:00one or two. So in that instance, they there would
- 30:04be guidance regarding addressing bifurcation
- 30:07and indicating what they're saying is clarifying
- 30:09the ways in which for businesses with multiple
- 30:12activities, how section 280E applies only to
- 30:15those activities related to trafficking in schedule
- 30:19one or two control substances. So there's gonna
- 30:22be a lot of questions about how people allocate
- 30:24and how they make these distinctions. There are
- 30:27another transition rule that would... there will
- 30:29be guidance with respect to actually transitioning
- 30:34and when the new classification would take effect
- 30:38for taxpayers' tax year. But certainly, guidance
- 30:41does indicate at least that rescheduling generally
- 30:44will be considered to first apply for a business's
- 30:47full taxable year that includes the effective
- 30:49date of final order. So in which case that is
- 30:55at least not pushing it to a year after the effective
- 30:58date. So there's lots of questions out there
- 31:02and supposedly guidance is on the way. Let's
- 31:09see what we have here. Thank you, thank you.
- 31:13For California operators, the tax treatment as
- 31:17I think Shay has mentioned and you know, we'll
- 31:22discuss it and we'll be discussing also. The
- 31:25tax analysis should be made cautious and very
- 31:27fact -specific. California is a dual -use state.
- 31:31There's medical marijuana operations as well
- 31:34as adult use, recreational use, and so forth.
- 31:38So businesses would presumably need to start
- 31:40distinguishing between the activities, reviewing
- 31:43licensed tax designations, allocating expenses
- 31:46among activities that would receive different
- 31:49federal treatment. and preserving documentation,
- 31:52supporting deduction positions. Until effective
- 31:56guidance is clear, operations should consider
- 31:59modeling kind of the potential tax treatment
- 32:02and also just kind of having careful compliance
- 32:06under the rules of fact currently, record keeping
- 32:09and audit readiness practices. But here also
- 32:12that leads to the issue of refund claims. Because
- 32:15while... You know, we shouldn't assume any sort
- 32:19of automatic retroactive relief, but also there
- 32:23may be, for instance, there may be issues with
- 32:25respect to guidance that suggests that there
- 32:29may be prior relief or there may be during this
- 32:32pending process until we know when this is. absolutely
- 32:38effective. We want to hold on to our receipts
- 32:42when we know exactly how she would be filing
- 32:45pursuant to this. We may have to go back or taxpayers
- 32:48may have to go back and possibly file amended
- 32:51returns. So really, as indicated, we want to
- 32:54keep track of open statute years, keep track
- 32:57of pending audits. This takes a while considering
- 33:00whether one should make a protective refund claim.
- 33:03And a protective refund claim really is about
- 33:05holding the statutory period, you know, holding
- 33:07actually the claim open until certain facts are
- 33:11determined or, you know, when there's pending
- 33:13litigation or other items to be resolved. So
- 33:18if we could go to the next page, please. So here
- 33:24we have issues with respect to mixed use. And
- 33:26again, just kind of thinking about where this
- 33:30is headed toward what seems to be possibly a
- 33:33dual use system, separating operations, thinking
- 33:37about possibly having different systems in terms
- 33:40of keeping up different books, in terms of keeping
- 33:44track or some way to keep track of allocating
- 33:47revenue, expenses. looking at, and there's different
- 33:52ways that the shared metrics to determine allocation,
- 33:55probably something that is contemporaneous and
- 33:57consistent would be helpful for now. When there
- 34:00is guidance, it could be, will probably be very
- 34:02specific. And people, again, may have to go back
- 34:05and kind of reevaluate what they've done, but
- 34:08certainly at least, you know, document and contemporaneous
- 34:11and being consistent. And probably, and I'm sure
- 34:15Aaron will discuss this more, businesses are
- 34:18going to start thinking about restructuring.
- 34:20or they're going to consider what their options
- 34:23are considering the new landscape and licensing
- 34:25taxation and so forth. Next slide, please. So
- 34:31state tax here, Eric, we've just, actually, I
- 34:35want to go to the next, I'll come back to 14.
- 34:38Could we go to the next slide, please? So here's
- 34:41just a checklist in terms of as operators are
- 34:45thinking, again, confirming licenses, activities,
- 34:50I won't go through this here. This is really
- 34:53just kind of a checklist to consider. And the
- 34:54next slide. Is this the last? Okay. So audit
- 35:00enforcement risks. And kind of, again, this is
- 35:02just for people who, it's just kind of a reminder
- 35:05as, you know, if it comes up, if one has an audit
- 35:10or wants to prepare for an audit, again, there's
- 35:12a reminder about preparing differently or being
- 35:15able to prove. both sets of classifications.
- 35:19So kind of finally, if we could go to page 14,
- 35:22for state considerations, and Shay referenced,
- 35:25you've referenced that different states have
- 35:27taken different positions with respect to their
- 35:31treatment. Some states have decoupled from the
- 35:35federal position, other states align completely
- 35:38with the federal position. But there are some
- 35:42states where the only thing that they allow is
- 35:46is a licensing for medical marijuana. And, you
- 35:51know, I guess a question there that I would have
- 35:52for you is for those states that do so, you know,
- 35:57and we've discussed it, it's probably gonna get
- 35:58a lot easier because if then they basically for
- 36:02anyone in that state is operating. that the 280E
- 36:06should, you know, they should not be subject,
- 36:09presumably it makes it easier for them. They
- 36:12won't really be subject to 280E if they're doing
- 36:14things properly, whereas places like California
- 36:17where there's dual use got more complicated.
- 36:19But I guess the question I have, outstanding,
- 36:21so Erin, kind of, I guess I'll ask, you know,
- 36:24you and Shay, even in a state, and kind of turn
- 36:27this over to you, but even in a state where it's
- 36:29just medical marijuana that's allowed, won't,
- 36:34You know, it's not as if people, is it that people
- 36:37can simply assume that they're no longer subject
- 36:39to this section and just operate, you know, accordingly?
- 36:44Or do they still have to monitor that they're
- 36:47meeting certain requirements for classification?
- 36:51You know, like in other words, are they just
- 36:53down here? Or are they still having, I guess
- 36:55they're still having to prove that they would
- 36:57qualify. Would that be right, like in terms of,
- 37:00and that's a question I could be, I don't know,
- 37:02so I'm asking like. make sure that there's been
- 37:04proper registration, licenses are proper, all
- 37:07of that, in order to qualify to then not be subject
- 37:10to ABE. Is that how it would work? Well, I'll
- 37:14just jump in real quick. The April 28th, 2026
- 37:19order rescheduled state licensed medicinal cannabis
- 37:25period. It doesn't say only if it qualifies.
- 37:30It doesn't say that, right? Okay. So it happened.
- 37:36Now, for IRS purposes, in order to actually take
- 37:43the benefit of the relief, you're going to have
- 37:48to show the IRS that you're entitled to it. I
- 37:54think as you just pointed out, Levon, in states
- 37:57like Florida or Oklahoma or other red states,
- 38:04primarily, it's a Republican administration,
- 38:08so go figure, right? That demonstration to the
- 38:13IRS of the legitimacy of your claim to that relief
- 38:19is handed to you. It's handed to you. Here in
- 38:24California, it's absolutely not. It's now an
- 38:28issue of like, okay, well, is this medical? Is
- 38:33this adult use? How much is which? Do I have
- 38:38the right license types? Have I segregated the
- 38:43revenue streams? Have I put the expenses where
- 38:47they're tied to the right? type of cannabis,
- 38:52right? So. Okay, interesting. I hear what you're
- 38:56saying and thank you. So then I'm gonna also
- 38:59though, also Aaron, what are you seeing that's
- 39:03happened since the order came through? I mean,
- 39:05is this something people are, you know, are paying
- 39:07attention to or everybody's kind of sitting on
- 39:09their hands, kind of waiting? I think there's
- 39:12a lot of uncertainty and amongst operators. to
- 39:18see how this plays out, especially with the EA
- 39:21registration. And if you want to pull up my deck,
- 39:24I can start going into some of those issues.
- 39:27Sure. So that would be perfect. Thank you. So
- 39:33hey, everyone. My name's Aaron Lashon. I'm with
- 39:37Leach Tischman. I want to thank Lavonne for inviting
- 39:41me to participate in this and I want to thank
- 39:44the Beverly Hills Bar Association and everyone
- 39:47who's attending. I see some familiar names from
- 39:49over the years so it's very cool to see the people
- 39:52who are here. I'm actually I'm going to talk
- 39:54about I guess the mechanics of what happened
- 39:57in the April 2026 order and we'll have some open
- 40:02discussion about what we know, what we're seeing,
- 40:05and how it all plays out. So I invite my co -panelists
- 40:08to chime in wherever they think it is relevant.
- 40:12So on April 28, 2026, Acting Attorney General
- 40:18Todd Blanch issued an order rescheduling state
- 40:23licensed medical marijuana and FDA approved THC
- 40:27drugs to schedule three. And that was the big
- 40:30change. It's actually a very limited change.
- 40:34The legal framework change, schedule one drugs
- 40:37have no recognized medical use and a high potential
- 40:40for abuse. Schedule three drugs have a lower
- 40:44potential for abuse and currently accepted medical
- 40:48treatment in the United States. So it was a monumental
- 40:50shift that we are now recognizing medical marijuana
- 40:55products. as legitimate medicine. In addition
- 41:00to just changing the status of the products,
- 41:03it required manufacturers, distributors, dispensers,
- 41:07and researchers to register with the DEA and
- 41:11obtain a Schedule III license. It created a new
- 41:17import -export pathway for folks who produce
- 41:20products to enter them into international commerce,
- 41:24but we don't have all the details on that and
- 41:27how it's going to be implemented. It changed
- 41:30the tax and financial effects, which Lavon spoke
- 41:33about and how it impacted 280E, and it introduced
- 41:38the DEA hearing, which was our first topic on
- 41:42broader rescheduling. The order and the rescheduling.
- 41:49was monumental for a couple of reasons. I think
- 41:52the most important one is that it's a primary
- 41:56shift because before we had everything is illegal
- 42:00under federal law and it carried tremendous business
- 42:04consequences that made operating your business
- 42:06very difficult. And then state legal cannabis
- 42:10adult use and medical to now we have federally
- 42:16recognized medical marijuana as well as state
- 42:20legal adult use, which is still subject to all
- 42:24of those onerous restrictions because it's considered
- 42:27federal one on the federal side or schedule one
- 42:30on the federal side. two separate tracks that
- 42:36we don't really know how they're going to play
- 42:38out and how they're going to interact with each
- 42:41other. And I just want to say for folks who may
- 42:43be watching this in the future on repeat, you
- 42:46know, everything I'm talking about is as of today,
- 42:49July 17th, 2026. A lot of this could change.
- 42:54There's currently lawsuits pending, challenging
- 42:56the rescheduling order altogether on administrative
- 43:00procedure at grounds. It's being challenged that
- 43:03it goes beyond the authority of the United States
- 43:06under federal narcotics treaties. So we're here
- 43:09today as a moment in time talking about how this
- 43:12is playing out and how folks are reacting to
- 43:17it. But what are the main benefits because of
- 43:20the rescheduling? I think for the folks who pursue
- 43:23the medical track, it's a tremendous opportunity
- 43:26because for the first time ever, it recognizes
- 43:29a medical cannabis as a legitimate... legal business
- 43:35that opens up more banking opportunities, capital
- 43:38opportunities, the possibility of bankruptcy
- 43:41if your business turns out to be a failure. Like
- 43:45I said before, there's going to be a contemplated
- 43:49import -export of cannabis products. It hasn't
- 43:53been released explicitly yet, but the guidance
- 43:56talks about commerce between the different DEA
- 44:00registered licensees. There's potential forthcoming
- 44:04interstate commerce that state regulatory programs
- 44:07are going to have to adjust to. It just opens
- 44:10up a different world of opportunity compared
- 44:13to the adult use providers who are going to continue
- 44:17to. try to swim with cement blocks on their feet,
- 44:23having to deal with I -280E, a completely intrastate
- 44:28market. While in the short term, it's great because
- 44:33the majority of cannabis purchasers are in the
- 44:38adult use states. California, New York, Illinois,
- 44:45there's tremendous business markets for adult
- 44:49use cannabis where it may not make sense to go
- 44:51for medical. It may not always be that way in
- 44:55the future if regulatory enforcement changes
- 44:58on the federal side and it becomes more of an
- 45:01issue. Operators here in California, I think
- 45:04they've got to balance different considerations
- 45:07as to what's happening in the short term, what's
- 45:10happening in the long term, what do the different
- 45:12markets look like, and what are their overall
- 45:16goals? Next slide. In response to this new opportunity,
- 45:25the Department of Cannabis Control in California,
- 45:28they passed emergency regulations that helped
- 45:32retailers split their businesses into separate
- 45:37adult use and medical licenses. I think this
- 45:41highlights the state was reactionary to this.
- 45:46It came out after the order was issued, but the
- 45:49state created opportunities to have a separate
- 45:54adult use business in one entity and a separate
- 45:57medical retail business in a second entity. And
- 46:00I think this was the state's attempt to keep
- 46:04the type of separation that the DEA is looking
- 46:07for in a truly medical program while allowing
- 46:11adult use operators to capitalize on the California
- 46:15marketplace. The biggest unknown and the biggest
- 46:19tension here, I think, is how is the DEA going
- 46:25to treat these businesses and states that have
- 46:28adult use? programs and how much does adult use
- 46:32become a disqualifying factor because it's outside
- 46:36of what's authorized in the federal system or
- 46:40beyond what they're willing to legalize. The
- 46:49state's emergency regulations, the overall theme
- 46:53is separations. It's a really easy process. The
- 46:59state has a form. It's form. 9207, it's processed
- 47:07within five days and it allows a retailer to
- 47:12submit a new entity to the state. As long as
- 47:16it has the exact same ownership as the adult
- 47:19use license business, it'll recognize the two
- 47:22separate businesses as one for California. Key
- 47:32consideration, what are the logistics of how
- 47:36it's going to be implemented? They're on the
- 47:38same premises, but it's separate inventory, separate
- 47:42records, and joint liability for any debts or
- 47:47enforcement that come along with the business.
- 47:50But the main goal, I think, was to help businesses
- 47:53who wanted to pursue the DEA emergency or the
- 47:57DEA registration. Next slide. The DEA created
- 48:04a registration pathway for dispensaries. Right
- 48:08now it's just been for dispensaries who want
- 48:11to register as medical marijuana dispensaries
- 48:15under the federal system. It's probably the most
- 48:20straightforward and simple application a marijuana
- 48:23business or cannabis business has ever encountered.
- 48:28ownership information, licensure information,
- 48:32the scope of what you're going to be doing. Are
- 48:34you going to be dispensing medical marijuana
- 48:36products? Do you intend to be doing adult use
- 48:40in the future? Then a regulatory history of the
- 48:43business and owners as far as losing licenses
- 48:47in the past, being subject to convictions. There's
- 48:52two questions that I think gives everybody a
- 48:55lot of consternation and it's questions surrounding,
- 49:00do you intend to do adult use cannabis? or have
- 49:04you and any of your operators and owners, your
- 49:09shareholders, have you been in violation of the
- 49:13Controlled Substances Act? And folks are really
- 49:16concerned about it because it is a, the latter
- 49:21question is an admission that you've. you're
- 49:24acting outside the program or you've acted outside
- 49:26the program. The DEA, when the order was issued,
- 49:31it called for a 60 -day expedited window for
- 49:35protection. You could continue operating while
- 49:38applications were pending. That question is really
- 49:42more concerning for folks who are registering
- 49:46outside that 60 day window if they're operating
- 49:50outside the 60 day window and they didn't register
- 49:52because again, they're admitting the violations.
- 49:55It's a lot of unknowns. I would say anyone who
- 49:59went through like the initial registrations in
- 50:022018 with the state of California, there's unknown
- 50:06causes a lot of heartburn. The one thing that
- 50:10I'm concerned about is, disclosure of criminal
- 50:17convictions in connection with ownership teams.
- 50:21You know, California Prop 64, despite its imperfection,
- 50:24had robust protections in place that were about
- 50:30restorative and reparative justice. It had a
- 50:33whole framework for evaluating operator convictions
- 50:36and determining whether or not they had been
- 50:40rehabilitated. Quite frankly, I don't think I've
- 50:43ever seen any instance where somebody who had
- 50:48a cannabis -related conviction had their license
- 50:50denied by the state of California. doesn't have
- 50:55that same framework in place. An area of concern
- 51:00is potentially what impact criminal convictions
- 51:04have in states that have emphasized reparative
- 51:08justice, had social equity programs where they
- 51:11were targeting businesses for folks who had previous
- 51:15encounters with law enforcement. But the overall
- 51:18feeling is just there's a lot of unknown with
- 51:22the DEA. They're supposed to review applications
- 51:25and the priority set within six months. It's
- 51:28not mandatory that everyone gets registered.
- 51:31They have discretionary review to deny applications
- 51:35that are outside the public interest or against
- 51:39the country's treaty obligations under the International
- 51:42Narcotics Treaty. Next slide, please. So this
- 51:50is interesting. This is just, you know, the...
- 51:54case study of what one multi -state operator
- 51:57did TruLeave to get themselves prepared. They
- 52:02actually did this before rescheduling, but it
- 52:06shows a framework of what a multi -state operator
- 52:11is doing in order to take full advantage of the
- 52:15legalized medical system. TruLeave spun off all
- 52:19of its mixed use, its adult use, cannabis businesses
- 52:24to an outside independent investor. The investor
- 52:28retains total control of it and they no longer
- 52:32consider it part of the truly portfolio even
- 52:35though they're still. deriving economics from
- 52:38it. According to Trulieve's federal filings,
- 52:41you know, they're a 100 % medical business now.
- 52:44All of their licenses and all of their properties
- 52:47are DEA registered, and they're just focusing
- 52:51on medical marijuana operations within the states
- 52:57that they're in and the DEA registered supply
- 53:00chain. And their whole goal is obviously getting
- 53:03listed on the public exchanges. and being able
- 53:06to function as a publicly traded company in the
- 53:10United States without having to play the games
- 53:13that other folks were doing and getting registered
- 53:16in Canada and other places. I'm not saying it's...
- 53:21what everyone should be doing, but it's just
- 53:23an example of how one business has positioned
- 53:29themselves out there. There's a large cultivator
- 53:32in central California. If you go and you look
- 53:36at their... their state licenses, all of their
- 53:40cultivation licenses right now are framed as
- 53:44medical for one of their biggest facilities.
- 53:46So again, it's these larger operators, even ones
- 53:50in California, by framing themselves as medical,
- 53:55they're positioning themselves to take part in
- 53:58this larger marketplace, presumably cultivators
- 54:01as industrial suppliers and enter this medical
- 54:06national framework contemplated by the order
- 54:09that will be built out. Next slide. What do we
- 54:18have? Knowns and unknowns. So we know everyone's
- 54:22going to have to register with the DEA. We know
- 54:25California right now has this spin -off. What
- 54:30we don't know, and I think I hinted at it before,
- 54:33is what the DEA is going to do under its public
- 54:35interest review. How much separation is truly
- 54:39gonna be required? It's interesting what California
- 54:42is doing, at least with the retailers, they're
- 54:47technically separated on the books, they have
- 54:49physical inventory separations, different computer
- 54:53systems. Is that going to be enough for the DEA
- 54:58when it's held by the same investors and the
- 55:01ownership has to match between the two entities?
- 55:03Is that going to be enough? separation for folks
- 55:07who are involved in the California review. How's
- 55:10the DEA going to treat adult use and whether
- 55:14or not that's going to be against the public
- 55:16interest and what broader rescheduling is going
- 55:19to look like. Shay, do you have anything to add
- 55:24on unknowns that you're paying attention to?
- 55:28Yeah, how many more up lists we get to the New
- 55:32York Stock Exchange? Well, you're just talking
- 55:36about TrueLeave. And this was a year ago. People
- 55:42were not talking about, oh, we're just a year
- 55:45away from TrueLeave. And then I think there was
- 55:48another California company that glass house that's
- 55:56also going up. I mean, I think that when you
- 56:02start having the, you know, public investing,
- 56:08like, you know, we were talking about preparing
- 56:09for this presentation, I remember saying to Lavon,
- 56:13you can walk out today and go buy stock in one
- 56:16of these companies right now, go call your broker
- 56:19right away. Like that's, that is a new thing.
- 56:24It's a new way of really interacting with the
- 56:29plant. I mean, this is, you know, not just use
- 56:34and consumption, but financial contracts and
- 56:41securities. And I think that's a whole other
- 56:45level of taking down stigma around the plant.
- 56:49Cool. Next slide. What are the new opportunities?
- 56:57I think we've at least hinted at it. There's
- 57:00going to be built out a national medical supply
- 57:05chain, and at least for California operators,
- 57:09dispensing doesn't, unless there's broader legalization
- 57:14federally, you know dispensing under the new
- 57:17framework may not make sense for most California
- 57:21operators because there's such a large number
- 57:24of adult use patients or adult use customers.
- 57:29I think Shay would agree with me that if a business
- 57:31in California a dispensary was a medical only
- 57:35dispensary. It would have no chance of surviving
- 57:38in the California marketplace. What the opportunities
- 57:43as a supplier are much more interesting if you're
- 57:48looking to. enter this federal regulated national
- 57:52marketplace. Cultivators and manufacturers of
- 57:55products. California cannabis has its own brand
- 58:00and those products or producers may have more
- 58:03opportunities in the marketplace to ship to other
- 58:06states. It's also interesting because the cultivators,
- 58:11assuming the DEA recognizes separation and allows
- 58:17folks to continue to participate in adult use,
- 58:20we may end up in a situation where California
- 58:23suppliers, cultivators and manufacturers, they
- 58:27can have their cake and eat it too, where they
- 58:30can supply. adult use dispensary even though
- 58:33they have a medical designation because anyone
- 58:36in anyone in California can purchase you can
- 58:39purchase anywhere in the supply chain as long
- 58:41as you're licensed but if the DEA doesn't disqualify
- 58:44adult use participation they could also as medical
- 58:47providers enter the licensed DEA supply chain
- 58:51but it's it's an it's an unknown at this point
- 58:54how they're going to treat that adult use component.
- 58:58State license still matter. you're one of these
- 59:03medical providers in a closed medical marketplace,
- 59:07you're really happy about all of this because
- 59:10you have all the protections of a legitimate
- 59:12business under federal law, and you have a closed
- 59:15marketplace with very, very little competition.
- 59:19I think folks in Pennsylvania or probably in
- 59:22Florida are probably thrilled right now. Medical
- 59:25import -export, it's going to be in It's going
- 59:29to be out there in the future. It'll be really
- 59:33exciting for folks who participate in that system
- 59:35to be able to export cannabis products around
- 59:38the world. That'll all be governed and subject
- 59:41to treaty limitations and a whole additional.
- 59:45host of international regulations. Researchers,
- 59:48this is, I don't think it's for the people on
- 59:50this call, but researchers don't have to jump
- 59:54through all the hoops to handle schedule one
- 59:56material now. There's a lower bar schedule three
- 59:58researcher. And so I imagine that there will
- 1:00:01be much more open research throughout. universities
- 1:00:05and medical centers across the country. And I
- 1:00:08would just look, just like we have a closed loop
- 1:00:12framework here in California, it looks like this
- 1:00:15federal system is going to be its own closed
- 1:00:18loop framework that goes across the country and
- 1:00:22potentially the rest of the world working within
- 1:00:25the confines of a medical cannabis framework.
- 1:00:31Next slide. And last one is for lawyers, taxes
- 1:00:39are exciting for businesses. I think the number
- 1:00:43one thing is still, who's your client? What's
- 1:00:47their goal? Are you working with a big, well
- 1:00:49-funded? group that has aspirations of having
- 1:00:53a national brand that may want to work on developing
- 1:00:57pharmaceutical products in the future, or digging
- 1:01:00into institutional capital to have a national
- 1:01:04business, or are you working with the mom and
- 1:01:07pop operator who just wants to have a dispensary
- 1:01:12in California? I think for them, all of this
- 1:01:17Medical registration, it probably doesn't make
- 1:01:20sense. This isn't an opportunity they'll be interested
- 1:01:22in pursuing. It's more towards the larger institutional,
- 1:01:29providers who have national and institutional
- 1:01:32aspirations. Separate entities, it's the true
- 1:01:38leave model going forward. Ownership being aligned
- 1:01:44or identical that again, it's a it's a it's a
- 1:01:46risk question Trueleaf has aligned ownership.
- 1:01:49They don't have identical ownership. They're
- 1:01:52they're trying to say that you know, we're completely
- 1:01:54hands -off on the adult use project and Looking
- 1:02:01at you know, I think everyone who's working within
- 1:02:04this system You're you're still following that
- 1:02:08rescheduling because it could become broader.
- 1:02:10It could be the same but whatever happens with
- 1:02:13the rescheduling, is your client positioned correctly
- 1:02:18to take part in this? Are they being structured
- 1:02:20with separate lines of revenue and different
- 1:02:27entities to take part of the medical operation
- 1:02:29or are they just being an adult use provider
- 1:02:33with like one company? That's all I have. Happy
- 1:02:36to answer any questions. Lavonne, if you have
- 1:02:38any discussion questions, I know we're nearing
- 1:02:41the end of our hour. There are fantastic discussion
- 1:02:46questions that, in fact, that you and Shay provided
- 1:02:51to me. We have reached the end of the hour. I
- 1:02:54want to thank you and Shay tremendously. And
- 1:02:57there's so many interesting issues and questions
- 1:02:59remaining. And what I'm wondering is, you know,
- 1:03:02if people have questions, they should contact
- 1:03:04you and Shay, your contact information is in
- 1:03:08the materials. I don't see any Q &A outstanding.
- 1:03:11So I think we're right on time. I bet there's
- 1:03:15one. And I guess I'm not seeing it. Okay. What
- 1:03:19are the thoughts about cannabis administration
- 1:03:22opportunity? Act that was introduced. This is
- 1:03:26the CAOA that would require the AG to remove
- 1:03:30marijuana from the Controlled Substances Act
- 1:03:33within 180 days, impose a 5 % federal excise
- 1:03:37tax on small to mid -sized cannabis producers,
- 1:03:40have a national age gate 21 and older, expunge
- 1:03:44records and all that stuff. My thought about
- 1:03:47this is it won't become law. It's not going to
- 1:03:50get signed into law. So don't be looking for
- 1:03:53that. But it is significant in that you have
- 1:03:56senators on record from Cory Booker to Chuck
- 1:04:03Schumer to however many can get on board with
- 1:04:08this saying with the unified voice, something
- 1:04:11that the movement has been saying for decades,
- 1:04:14for as long as I've been alive certainly, that
- 1:04:17this should not be on the schedule. Very good.
- 1:04:22Aaron, did you have any comment on that? Nothing
- 1:04:24to add other than if it moves into a de -scheduled
- 1:04:27position, any sort that would presumably open
- 1:04:31interstate commerce, any sort of nationalized
- 1:04:35standards and packaging and labeling would probably
- 1:04:39good things as this continues to grow and moves
- 1:04:42into interstate and international commerce. It
- 1:04:45would be a nightmare to have to deal with 50
- 1:04:48state regulatory regimes when moving products
- 1:04:51between states and interstate commerce. All right,
- 1:04:56very good. Shay Gilmore, Erin LeChant, thank
- 1:05:00you, Beverly Hills Bar Association and participants
- 1:05:03on the program. Attendees, thank you all and
- 1:05:07have a very nice, I think we are done and have
- 1:05:10a very nice rest of your day, everyone.